Completed Monitoring COVID-19 Vaccination Response in Fragile Populations NCT05222139 Conditions Breakthrough Infection, Breakthrough Infections, COVID-19, +16 more Locations Universidad de Buenos Aires (UBA) — Buenos Aires, Argentina Centre de Recherches Medicales de Lambaréné (CERMEL) — Lambaréné, Gabon Catholics Bishops Conference of India, Society for Medical Education (CBCI) — Bangalore, India Translational Health Science and Technology Institute (THSTI) — Faridabad, India View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States NCT05020145 Conditions Breakthrough Infection, Breakthrough Infections, COVID-19, +18 more Locations Pfizer Inc. — New York, United States View Trial Details
Completed Antibody After COVID-19 Vaccination NCT05057936 Conditions Breakthrough Infection, Breakthrough Infections, CKD, +27 more Locations Faculty of Medicine,Vajira Hospital — Bangkok, Thailand View Trial Details
